Abingdon Life Sciences names new vice president of regulatory science

Mr Davis joins Abingdon from Santarus Pharmaceuticals where he was senior director of regulatory affairs. Mr Davis, with over 20 years of regulatory experience, has brought both drug and biologic products to commercial launch in the fields of cardiac imaging, coronary angioplasty, oncology, gastroenterology, parenteral nutrition, ophthalmology and contraception.

Aidan Nuttall, Abingdon’s president and COO, said: Charley brings a wealth of experience to the company. He is a proven leader and has an extremely successful track record in regulatory affairs. He will certainly be a powerful asset to our clients.